Phase 1 dose-escalation study of EBC-46 given by intratumoral injection to patients with refractory cutaneous and subcutaneous tumors.

Citation

• Lickliter, J. D., Panizza, B., Karapetis, C. S., Gordon, V. A., Reddell, P. W., Lingard, K. T., . . . De Souza, P. (2015). Phase 1 dose-escalation study of EBC-46 given by intratumoral injection to patients with refractory cutaneous and subcutaneous tumors.. Journal of Clinical Oncology, 33(15_suppl), tps2616. doi:10.1200/jco.2015.33.15_suppl.tps2616

Digital Object Identifier (doi)

• 10.1200/jco.2015.33.15_suppl.tps2616

Web Of Science Accession Number

Start Page

• tps2616

End Page

• tps2616

Volume

• 33

Issue

• 15_suppl

Place Of Publication

Abstract

UOW Authors

•   De Souza, Paul (external author)

Publication Date

• 2015

Publisher

• American Society of Clinical Oncology (ASCO) 

Published In

• Journal of Clinical Oncology  Journal

Citation

• Lickliter, J. D., Panizza, B., Karapetis, C. S., Gordon, V. A., Reddell, P. W., Lingard, K. T., . . . De Souza, P. (2015). Phase 1 dose-escalation study of EBC-46 given by intratumoral injection to patients with refractory cutaneous and subcutaneous tumors.. Journal of Clinical Oncology, 33(15_suppl), tps2616. doi:10.1200/jco.2015.33.15_suppl.tps2616

Digital Object Identifier (doi)

• 10.1200/jco.2015.33.15_suppl.tps2616

Web Of Science Accession Number

Start Page

• tps2616

End Page

• tps2616

Volume

• 33

Issue

• 15_suppl

Place Of Publication